Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - EP …, 2020 - academic.oup.com
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher… - … : journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - EP-Europace, 2019 - hal.science
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - 2019 - lilloa.univ-lille.fr
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients
with atrial fibrillation in a nationwide cohort study Toggle navigation English français Aide …
with atrial fibrillation in a nationwide cohort study Toggle navigation English français Aide …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - EP …, 2020 - academic.oup.com
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study.
L Fauchier, P Blin, F Sacher… - … : Journal of the …, 2020 - europepmc.org
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
[PDF][PDF] Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - Europace, 2020 - researchgate.net
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients
with atrial fibrillation in a nati Page 1 Reduced dose of rivaroxaban and dabigatran vs. vitamin …
with atrial fibrillation in a nati Page 1 Reduced dose of rivaroxaban and dabigatran vs. vitamin …
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
L Fauchier, P Blin, F Sacher, C Dureau-Pournin… - EP-Europace, 2020 - hal.science
Aims The real-life benefits and risks of the non-vitamin K antagonist oral anticoagulants for
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …
stroke prevention in very elderly patients with atrial fibrillation (AF) are still debated. Methods …